Spruce biosciences presents phase 2 data for tildacerfont in adults with congenital adrenal hyperplasia at 23rd european congress of endocrinology

San francisco--(business wire)---- $sprb #ece2021--spruce biosciences presents phase 2 data for tildacerfont in adults with congenital adrenal hyperplasia at 23rd european congress of endocrinology
SPRB Ratings Summary
SPRB Quant Ranking